Mohammed Gbadamosi, Ph.D.

Dr. Mohammed Gbadamosi is an Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida College of Pharmacy.

Dr. Gbadamosi completed his graduate studies in the Department of Pharmacotherapy and Translational Research at the University of Florida College of Pharmacy. Thereafter, He completed his postdoctoral training as an NIH T32 Postdoctoral Fellow in the Program for Applied Research and Development in Genomic Medicine (PARADIGM).

In 2023, Dr. Gbadamosi was selected as one of thirteen individuals to receive the highly prestigious NIH Director’s Early Independence Award, launching his independent research career. Dr. Gbadamosi now leads a collaborative multidisciplinary research group that uses advanced molecular, cellular, and computational approaches to optimize immune responses to chemotherapy (chemoimmunomodulation), which play a major role in long-term clinical outcomes. His research spans basic and translational sciences with the ultimate end goal of understanding, predicting, and optimizing chemoimmunomodulation toward maximizing patient benefit from chemotherapy.

Dr. Gbadamosi also holds membership in the University of Florida Brain Tumor Immunotherapy Program and Preston A. Wells, Jr. Center for Brain Tumor Therapy where he leads studies focused on developing and characterizing models of triple-negative breast cancer brain metastases and identifying novel approaches towards a cure.

Dr. Gbadamosi’s leadership at the University of Florida has driven transformative initiatives, effecting policy changes and fostering academic excellence. His notable contributions include founding the College of Pharmacy Graduate Student Organization, serving on the College of Pharmacy Dean’s Leadership Council (2020-2023), and serving on the College of Pharmacy Strategic Vision board. Dr. Gbadamosi has a passion for serving the next generation of trainees and students as a mentor, providing advocacy, opportunities, and experiences that enable them to succeed. This includes mentoring undergraduate, graduate, and professional students and actively serves as a director for the PARADIGM program. Dr. Gbadamosi is an ad-hoc member of several NIH Study sections, is a Fellow of the Cancer Research Education and Engagement (CaRE2) Health Equity Center, and contributes as a reviewer for esteemed journals.